FOXP3 and type 1 diabetes mellitus: miR-210-3p, upregulated in the plasma, serum, and urine of pediatric T1D patients, downregulates FOXP3, a key regulator of Treg function, impairing immune tolerance and exacerbating autoimmunity [32,136].